Skip to main content
SpringerLink
Log in

Cancer du sein métastatique

  • Chapter
Cancer du sein en situation métastatique

  • 232 Accesses

Résumé

Sept études sont actuellement publiées, évaluant le rôle potentiel de la chirurgie d’exérèse de la tumeur primitive sur la survie des patientes avec un cancer métastatique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Abdalla EK, Pisters PW (2002) Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol 3: 497–505

    Article  PubMed  Google Scholar 

  2. Abitabile P, Hartl U, Lange J, Maurer CA (2007) Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 33: 67–71

    PubMed  CAS  Google Scholar 

  3. Adam R, Aloia T, Krissat J et al. (2006) Is liver resection justified for patients with hepatic metastases from breast cancer. Ann Surg 244: 897–908

    Article  PubMed  Google Scholar 

  4. Agarawal JP, Swangsilpa T, van den Linden Y et al. (2006) The role of external beam radiotherapy in the management of bone metastases. Clin Oncol 18: 747–760

    Article  CAS  Google Scholar 

  5. Alba E, Ruiz-Borrego M, MartÍn M et al. (2007) Prolongation of TTP by maintenance therapy with PLD in a multicenter phase III randomized trial following standard chemotherapy for MBC: GEICAM 2001-01 study. ASCO 2007 Annual Meeting Proceedings Part I. J Clin Oncol 25(18S): 1007

    Google Scholar 

  6. Aloia TA, Vauthey JN, Loyer EM et al. (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141: 460–466; discussion 466–7

    Article  PubMed  Google Scholar 

  7. Ambrogi MC, Lucchi M, Dini P et al. (2006) Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 30: 177–183

    Article  PubMed  Google Scholar 

  8. Andrew DW, Scott CB, Sperduto PW et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665–1672

    Article  Google Scholar 

  9. Aoyama H, Shirato H, Tago M et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483–2491

    Article  PubMed  CAS  Google Scholar 

  10. Babiera GV, Rao R, Feng L et al. (2006) Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13: 776–782

    Article  PubMed  Google Scholar 

  11. Bafford AC, Burstein HJ, Barkley CR et al. (2009) Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat 115: 7–12

    Article  PubMed  Google Scholar 

  12. Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. AJR Am J Roentgenol 184: 1096–1102

    PubMed  Google Scholar 

  13. Bartelink H, Horiot JC, Poortmans PM et al. (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus non boost EORTC 22881-10882 TRIAL. J Clin Oncol 25: 3259–3265

    Article  PubMed  Google Scholar 

  14. Bartsch R, Fromm S, Rudas M et al. (2006) Intensified local treatment and systemic therapy significantly increase survival in patients with Brain metastases from advanced breast cancer — a retrospective analysis. Radiother Oncol 80: 313–317

    Article  PubMed  Google Scholar 

  15. Baselga J, Carbonell X, Castaneda-Soto NJ et al. (2005) Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule. J Clin Oncol 23: 2162–2171

    Article  PubMed  CAS  Google Scholar 

  16. Baselga J, Tripathy D, Mendelsohn J et al. (1999) Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol 26(4 Suppl 12): 78–83

    PubMed  CAS  Google Scholar 

  17. Baslaim MM, Bakheet SM, Bakheet R et al. (2003) 18-Fluorodeoxyglucosepositron emission tomography in inflammatory breast cancer. World J Surg 27: 1099–1104

    Article  PubMed  Google Scholar 

  18. Bathe OF, Kaklamanos IG, Moffat FL et al. (1999) Metastasectomy as a cytorective strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer. Surgical Oncol 8: 35–42

    Article  CAS  Google Scholar 

  19. Baum M, Demicheli R, Hrushesky W et al. (2005) Does surgery unfavourably perturb the « natural history » of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41: 508–515

    Article  PubMed  Google Scholar 

  20. Bausewein C, Kuhnbach R, Haberland B (2006) Adrenal insufficiency caused by bilateral adrenal metastases — a rare treatable cause for recurrent nausea and vomiting in metastatic breast cancer. Onkologie 29: 203–205

    Article  PubMed  Google Scholar 

  21. Bellon JR, Livingston RB, Eubank WB et al. (2004) Evaluation of the internal mammary lymph nodes byFDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 27: 407–410

    Article  PubMed  Google Scholar 

  22. Berber E, Ari E, Herceg N, Siperstein A (2005) Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc 19: 1613–1617

    Article  PubMed  CAS  Google Scholar 

  23. Bilchik AJ, Wood TF, Allegra D et al. (2000) Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 135: 657–662; discussion 662–54

    Article  PubMed  CAS  Google Scholar 

  24. Blanchard DK, Shetty PB, Hilsenbeck SG et al. (2008) Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 247: 732–738

    Article  PubMed  Google Scholar 

  25. Blanco G, Holli K, Heikkinen M, Kallioniemi OP, Taskinen P (1990) Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 62: 142–146

    Article  PubMed  CAS  Google Scholar 

  26. Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55: 1468–1472

    Article  PubMed  CAS  Google Scholar 

  27. Body JJ et al. (2003) Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases. Ann Oncol 14: 1399–1405

    Article  PubMed  Google Scholar 

  28. Body JJ et al. (2004) Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from randomised, placebo-controlled phase III studies. Br J Cancer 90: 1133–1137

    Article  PubMed  CAS  Google Scholar 

  29. Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 185: 466–471

    PubMed  Google Scholar 

  30. Boogerd W, Vos VW, Hart AAM et al. (1993) Brain metastases in breast cancer: natural history, prognostic factors and outcome. J Neuro Oncol 15: 165–174

    Article  CAS  Google Scholar 

  31. Burstein HJ, Winer EP (2005) HER2 or not HER2: that is the question. J Clin Oncol 23: 3656–3659

    Article  PubMed  Google Scholar 

  32. Cabarrot E (2000) Histoire naturelle des cancers du sein. Paris: EMC. Elsevier-Masson

    Google Scholar 

  33. Cameron D, Casey M, Press M et al. (2008) A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyse. Breast Cancer Res Treat 112: 533–543

    Article  PubMed  CAS  Google Scholar 

  34. Cancello G, Montagna E, D’Agostino D et al. (2008) Continuing Trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer 1. Breast Cancer Res 10(4): R60

    Article  PubMed  CAS  Google Scholar 

  35. Caralt M, Bilbao I, Cortes J et al. (2008) Hepatic resection for liver metastases as part of the “oncosurgical” treatment of metastatic breast cancer. Ann Surg Oncol 15: 2804–2810

    Article  PubMed  Google Scholar 

  36. Carlini M, Lonardo MT, Carboni F et al. (2002) Liver metastases from breast cancer: results of surgical resection. Hepatogastroenterology 49: 1597–1601

    PubMed  Google Scholar 

  37. Carlsson J, Nordgren H, Sjostrom J et al. (2004) HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer 90: 2344–2348

    PubMed  CAS  Google Scholar 

  38. Carrafiello G, Lagana D, Recaldini C et al. (2008) Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: preliminary results at a single institution with a single device. Cardiovasc Intervent Radiol 31: 762–767

    Article  PubMed  CAS  Google Scholar 

  39. Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Cherry SR (2006) Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl Med 47: 1968–1976

    PubMed  Google Scholar 

  40. Chang EY, Johnson W, Karamlou K et al. (2006) The evaluation and treatment implication of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg 191: 641–645

    Article  PubMed  Google Scholar 

  41. Chen MS, Zhang YJ, Li JQ et al. (2007) Experience of radiofrequency ablation on liver malignancies: a report of 803 cases. Zhonghua Wai Ke Za Zhi 45: 1469–1471

    PubMed  Google Scholar 

  42. Chiras J, Adem C, Vallee JN, Spelle L, Cormier E, Rose M (2004) Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol 10: 1774–1780

    Google Scholar 

  43. Chiras J, Barragan-Campos HM, Cormier E, Jean B, Rose M (2007) Radiologie interventionnelle des metastases osseuses. Bull Cancer 94: 161–169

    PubMed  Google Scholar 

  44. Chougule PB, Burton-Williams M, Saris S et al. (2000) Randomized treatment of brain metastasis with Gamma knife radiosurgery, whole brain radiotherapy or both. Proc. Amer. Soc. Ther Rad Oncol 48(Suppl): 114 (abstract 7)

    Google Scholar 

  45. Chow DH, Sinn LH, Ng KK et al. (2006) Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study. J Surg Oncol 94: 565–571

    Article  PubMed  Google Scholar 

  46. Chow E, Hoskin PJ, WU J et al. (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases. National Cancer Institute of Canada Trials Group (NCIC CTG) SC 20. Clin Oncol 18: 125–128

    Article  CAS  Google Scholar 

  47. Church DN, Modgil R, Guglani S et al. (2008) Extended survival in women with brain metastases from HER2 overexpressing breast cancer. Am J Clin Oncol 31: 250–254

    Article  PubMed  CAS  Google Scholar 

  48. Civalleri D, Scopinaro G, Balletto N et al. (1989) Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres. Br J Surg 76: 699–703

    Article  PubMed  CAS  Google Scholar 

  49. Clark GM, Sledge GW, Jr., Osborne CK, McGuire WL (1987) Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5: 55–61

    PubMed  CAS  Google Scholar 

  50. Cobleigh MA, Vogel C et al. (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17: 2639–2648

    PubMed  CAS  Google Scholar 

  51. Coffey JC, Wang JH, Smith MJ et al. (2003) Excision surgery for cancer cure: therapy at a cost. Lancet Oncol 4: 760–768

    Article  PubMed  CAS  Google Scholar 

  52. Coldwell DM, Sewell PE (2005) The expanding role of interventional radiology in the supportive care of the oncology patient: from diagnosis to therapy. Semin Oncol 32: 169–173

    Article  PubMed  Google Scholar 

  53. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61–66

    Article  PubMed  CAS  Google Scholar 

  54. Coleman RE, Smith P, Rubens RD (1998) Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77: 336–340

    Article  PubMed  CAS  Google Scholar 

  55. Conte PF et al. (1996) Delay progression of bone metastases in breast cancer patients treated with intravenous pamidronate. Results from a multinational randomized controlled trial. J Clin Oncol 14: 2552–2559

    PubMed  CAS  Google Scholar 

  56. Cook GJ, Houston S, Rubens R et al. (1998) Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16: 3375–3379

    PubMed  CAS  Google Scholar 

  57. Cooper IS, Hirose T (1966) Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med 274: 15–18

    Article  PubMed  CAS  Google Scholar 

  58. Cotten A, Deprez X, Migaud H, Chabanne B, Duquesnoy B, Chastanet P (1995) Malignant acetabular osteolyses: percutaneous injection of acrylic bone cement. Radiology 1: 307–310

    Google Scholar 

  59. Couturier O, Jerusalem G, N’Guyen JM, Hustinx R (2006) Sequential positron emission tomography using (18F)fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer. Clin Cancer Res 12: 6437–6443

    Article  PubMed  CAS  Google Scholar 

  60. Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM, Preskitt JT (1997) Cryosurgical ablation of hepatic tumors. Am J Surg 174: 614–617; discussion 617–8

    Article  PubMed  CAS  Google Scholar 

  61. Curley SA (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15: 11–13

    Article  PubMed  Google Scholar 

  62. D’Annibale M, Piovanello P, Cerasoli V et al. (2005) Liver metastases from breast cancer: the role of surgical treatment. Hepatogastroenterology 52: 1858–1862

    PubMed  Google Scholar 

  63. Dale PS, Souza JW, Brewer DA (1998) Cryosurgical ablation of unresectable hepatic metastases. J Surg Oncol 68: 242–245

    Article  PubMed  CAS  Google Scholar 

  64. Davis PC, Hudgins PA, Peterman SB, Hoffman JC (1991) Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR 12: 293–300

    PubMed  CAS  Google Scholar 

  65. Dawood S, Broglio K, Esteva FJ et al. (2008) Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol 19: 1242–1248

    Article  PubMed  CAS  Google Scholar 

  66. de Baere T, Palussiere J, Auperin A et al. (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum followup of 1 year: prospective evaluation. Radiology 240: 587–596

    Article  PubMed  Google Scholar 

  67. de Baere T (2005) Radiofrequency in cancerology. Bull Cancer 92: 65–74

    PubMed  Google Scholar 

  68. de la Monte SM, Hutchins GM, Moore GW (1984) Endocrine organ metastases from breast carcinoma. Am J Pathol 114: 131–136

    PubMed  Google Scholar 

  69. Di Leo A, Gomez HL, Aziz Z et al. (2008) Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. J Clin Oncol 26: 5544–5552

    Article  PubMed  CAS  Google Scholar 

  70. Diel IG et al. (1998) Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339: 357–363

    Article  PubMed  CAS  Google Scholar 

  71. Diel IJ et al. (1999) Continual oral versus intravenous interval therapy with biphosphonate in patients with breast cnacer and bone metastases. Proceeding of ASCO 18: A:488

    Google Scholar 

  72. Donckier V, Van Laethem JL, Goldman S et al. (2003) (F-18) fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84: 215–223

    Article  PubMed  Google Scholar 

  73. Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Jänicke F, Avril N (2005) Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med 46: 1144–1150

    PubMed  Google Scholar 

  74. Dromain C, de Baere T, Elias D et al. (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223: 255–262

    Article  PubMed  Google Scholar 

  75. Elias D, Lasser PH, Montrucolli D, Bonvallot S, Spielmann M (1995) Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol 21: 510–513

    Article  PubMed  CAS  Google Scholar 

  76. Elias D, Maisonnette F, Druet-Cabanac M et al. (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185: 158–164

    Article  PubMed  Google Scholar 

  77. Elomaa I et al. (1988) Clodronate for osteolytic metastases due to breast cancer. Biomed & Pharmacother 42: 111–116

    CAS  Google Scholar 

  78. Ercolani G, Grazi GL, Ravaioli M et al. (2005) The role of liver resections for non colorectal, nonendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 12: 459–466

    Article  PubMed  Google Scholar 

  79. Eubank WB, Mankoff D, Bhattacharya M et al. (2004) Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer. Am J Roentgenol 183: 479–486

    Google Scholar 

  80. Ewer MS, Lippman SM (2005) Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 23: 2900–2902

    Article  PubMed  CAS  Google Scholar 

  81. Fabi A, Metro G, Ferretti G et al. (2008) Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies 3. Breast 17: 499–505

    Article  PubMed  Google Scholar 

  82. Fields RC, Jeffe DB, Trinkhaus K et al. (2007) Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 14: 3345–3351

    Article  PubMed  Google Scholar 

  83. Fountzilas G, Dafni U, Dimopoulos MA et al. (2008) A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: A Hellenic Cooperative Oncology Group study. Breast Cancer Res Treat 115: 87–99

    Article  PubMed  CAS  Google Scholar 

  84. Fountzilas G, Razis E, Tsavdaridis D et al. (2003) Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group 6. Clin Breast Cancer 4: 120–125

    Article  PubMed  CAS  Google Scholar 

  85. Frezza EE, Wachtel MS, Barragan B, Chiriva-Internati M, Cobos E (2007) The role of radiofrequency ablation in multiple liver metastases to debulk the tumor: a pilot study before alternative therapies. J Laparoendosc Adv Surg Tech A 17: 282–284

    Article  PubMed  Google Scholar 

  86. Friedel G, Pastorino U, Ginsberg RJ et al.; International Registry of Lung Metastases, London, England (2002) Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 22: 335–344

    Article  PubMed  Google Scholar 

  87. Fromigue J, De Baere T, Baudin E, Dromain C, Leboulleux S, Schlumberger M (2006) Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab 91: 2496–2499

    Article  PubMed  CAS  Google Scholar 

  88. Gadaleta C, Catino A, Mattioli V (2006) Radiofrequency thermal ablation in the treatment of lung malignancies. in vivo 20: 765–767

    PubMed  Google Scholar 

  89. Gadaleta C, Catino A, Ranieri G et al. (2004) Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother 16(Suppl 5): 86–89

    PubMed  Google Scholar 

  90. Gancberg D, Leo A, Di F et al. (2002) Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol 13: 1036–1043

    Article  PubMed  CAS  Google Scholar 

  91. Gangi A, Buy X (2007) Interventional radiology in lung cancer: from diagnosis to treatment. Rev Mal Respir 24: 6S137–6S145

    PubMed  CAS  Google Scholar 

  92. Gaspar L, Scott C, Rotman M et al. (1997) Recursive Partitioning Analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745–751

    Article  PubMed  CAS  Google Scholar 

  93. Gasparini G, Gion M, Mariani L et al. (2007) Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer 7. Breast Cancer Res Treat 101: 355–365

    Article  PubMed  CAS  Google Scholar 

  94. Gennari A, Sormani M, Bruzzi P, Wilcken N, Nanni O, Fornier M, Stockler MR (2008) A meta-analysis of chemotherapy duration in metastatic breast cancer (MBC). J Clin Oncol 26(Suppl): abstract 1067

    Google Scholar 

  95. Geyer CE, Forster J, Lindquist D et al. (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer 1. N Engl J Med 355: 2733–2743

    Article  PubMed  CAS  Google Scholar 

  96. Gillams AR, Lees WR (2008) Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19: 712–717

    Article  PubMed  Google Scholar 

  97. Gillams AR, Lees WR (2008) Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 18: 672–677

    Article  PubMed  Google Scholar 

  98. Gillams AR (2005) Complications of percutaneous therapy. Cancer Imaging 5: 110–113

    Article  PubMed  CAS  Google Scholar 

  99. Giorgio A, Tarantino L, De Stefano G et al. (2000) The echo-guided interstitial laser photocoagulation of malignant liver tumors. The authors’ personal technic, immediate results and short-term complications in patients with normal and altered liver function. Radiol Med 99: 264–269

    CAS  Google Scholar 

  100. Giorgio A, Tarantino L, de Stefano G et al. (2000) Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound 11: 181–188

    Article  PubMed  CAS  Google Scholar 

  101. Giovannini M, Seitz JF, Rosello R, Gauthier A (1989) Treatment of minor hepatic tumors with ultrasonically guided percutaneous injection of absolute alcohol. Results in 8 patients. Gastroenterol Clin Biol 13: 974–977

    PubMed  CAS  Google Scholar 

  102. Giroux MF, Baum RA, Soulen MC (2004) Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol 15: 289–291

    PubMed  Google Scholar 

  103. Gnant M, Mlineritsch B, Schippinger W et al. (2008) Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12. J Clin Oncol 26(Suppl): abstract LBA4

    Google Scholar 

  104. Gnerlich J, Jeffe DB, Deshpande AD et al. (2007) Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER Data. Ann Surg Oncol 14: 2187–2194

    Article  PubMed  Google Scholar 

  105. Goetz MP, Callstrom MR, Charboneau JW et al. (2004) Percutaneous imageguided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22: 300–306

    Article  PubMed  Google Scholar 

  106. Goyal S, Prasad D, Harrell F Jr et al. (2005) Gamma knife surgery for the treatment of intracranial metastases from breast cancer. J Neurosurg 103: 218–223

    Article  PubMed  Google Scholar 

  107. Gu YK, Fan WJ, Huang JH, Zhang L, Gao F (2007) Efficacy of CT-guided intra-tumoral dehydrated ethanol injection on lung metastasis from liver cancer. Ai Zheng 26: 1112–1115

    PubMed  Google Scholar 

  108. Guastalla JP, Catimel G, Blay JY et al. (1997) Traitement du cancer du sein métastatique et des formes cliniques particulières. Encycl Med Chir (Paris, Elsevier-Masson)

    Google Scholar 

  109. Haemmerich D, Laeseke PF (2005) Thermal tumour ablation: devices, clinical applications and future directions. Int J Hyperthermia 21: 755–760

    Article  PubMed  CAS  Google Scholar 

  110. Hamberg P, Bontenbal M, Vernhout RM et al. (2007) Combined trastuzumab (HER)/docétaxel (TAX) versus sequential trastuzumab followed by docétaxel at progression as first line chemotherapy for Her2-positive metastatic breast cancer: preliminary results (multicenter BOOG-study; 2002-02). SABCS 2007: abstract 1077

    Google Scholar 

  111. Hamid O, O’Day S (2006) Commentary on stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. Am J Hematol Oncol 5: 629–633

    Google Scholar 

  112. Hayashi AH, Silver SF, van der Westhuizen NG et al. (2003) Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 185: 429–435

    Article  PubMed  Google Scholar 

  113. Helweg-Larsen S, Sorensen PS, Kreiner S (2000) Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46: 1163–1169

    Article  PubMed  CAS  Google Scholar 

  114. Hinshaw JL, Lee FT Jr. (2007) Cryoablation for liver cancer. Tech Vasc Interv Radiol 10: 47–57

    Article  PubMed  Google Scholar 

  115. Hiraki T, Tajiri N, Mimura H et al. (2006) Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 241: 275–283

    Article  PubMed  Google Scholar 

  116. Ho AS, Picus J, Darcy MD et al. (2007) Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. Am J Roentgenol 188: 1201–1207

    Article  Google Scholar 

  117. Hodgson NC, Gulenchyn KY (2008) Is there a role for positron emission tomography in breast cancer staging? J Clin Oncol 26: 712–720

    Article  PubMed  Google Scholar 

  118. Hoe AL, Royle GT, Taylor I (1991) Breast liver metastases—incidence, diagnosis and outcome. J R Soc Med 84: 714–716

    PubMed  CAS  Google Scholar 

  119. Hoh CK, Schiepers C, Seltzer MA et al. (1997) PET in oncology: Will it replace other modalities? Semin Nucl Med 27: 94–106

    Article  PubMed  CAS  Google Scholar 

  120. Hortobalgyi GN et al. (1998) Long term prevention of skeletal complication of metastatic breast cancer with pamidronate. J Clin Oncol 16: 2038–2044

    Google Scholar 

  121. Horvath LJ, Burtness BA, McCarthy S, Johnson KM (1999) Total-body echoplanar MR imaging in the staging of breast cancer: comparison with conventional methods-early experience. Radiology 211: 119–128

    PubMed  CAS  Google Scholar 

  122. Hultborn R et al. (1999) Efficacy of pamidronate in breast cancerwith bone metastases: A randomized, double bind placebo controlled muticenter study. Anticancer Research 19: 3383–3392

    PubMed  CAS  Google Scholar 

  123. Isasi CR, Moadel RM, Blaufox MD (2005) A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90: 105–112

    Article  PubMed  CAS  Google Scholar 

  124. Jackisch C, Eustermann H, Schoenegg W et al. (2007) Clinical use of trastuzumab (Herceptin ) in metastatic breast cancer (MBC) in Germany from 2001 to 2006. SABCS 2007: abstract 4059

    Google Scholar 

  125. Jaeck D, Schaal JC (1992) Autres traitements locaux. In: Nordlinger B, Jaeck D eds. Monographies de l’association française de chirurgie: traitement des métastases hépatiques des cancers colorectaux. Paris: Springer-Verlag

    Google Scholar 

  126. Jagdev SP et al. (2001) Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease. Ann Oncol 12: 1433–1438

    Article  PubMed  CAS  Google Scholar 

  127. Jeffrey SS, Birdwell RL, Ikeda DM et al. (1999) Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 134: 1064–1068

    Article  PubMed  CAS  Google Scholar 

  128. Jeon SH, Park KS, Kim YH et al. (2007) Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma. Korean J Gastroenterol 50: 176–182

    PubMed  Google Scholar 

  129. Johansen R, Westin AA, Bofin AM et al. (2008) Outcome of Whole-brain irradiation for breast cancer patients. Acta Oncol 47: 261–266

    Article  PubMed  Google Scholar 

  130. Johnston S, Pegram M, Press M et al. (2008) First line therapy with lapatinib combined with letrozole vs letrozole alone for post menopausal hormone receptor positive MBC: first results from the phase III double blind EGF30008 trial. Cancer Res 69: 74s, SABCS 2008, San Antonio, Texas

    Google Scholar 

  131. Journé F, Magné N, Chaboteaux C et al. (2006) Sequence-and concentrationdependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines. Clin Exp Metastasis 23: 135–147

    Article  PubMed  CAS  Google Scholar 

  132. Junginger T, Seifert JK, Weigel TF, Heintz A, Kreitner KF, Gerharz CD (1998) Cryotherapy of liver metastases. Initial results.Med Klin (Munich) 93: 517–523

    Article  CAS  Google Scholar 

  133. Jungraithmayr W, Burger D, Olschewski M, Eggstein S (2005) Cryoablation of malignant liver tumors: results of a single center study. Hepatobiliary Pancreat Dis Int 4: 554–560

    PubMed  Google Scholar 

  134. Kanis JA et al. (1996) Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone 19: 663–667

    Article  PubMed  CAS  Google Scholar 

  135. Kaufman B, Mackey J, Clemens M (2006) Trastuzumab plus anastrozole prolongs progression-free survival in postmenopausal women with HER2-positive, hormone-dependent metastatic breast cancer. Ann Oncol 17: ESMO

    Google Scholar 

  136. Khan SA, Stewart AK, Morrow M (2002) Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132: 620–627

    Article  PubMed  Google Scholar 

  137. Khono N et al. (2005) Zoledromic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: A randomized, placebo-controlled trial. J Clin Oncol 23: 3314–3321

    Article  CAS  Google Scholar 

  138. Khuntia D, Brown P, Li J et al. (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24: 1295–1304

    Article  PubMed  CAS  Google Scholar 

  139. Kleinberg LR (2006) Focal management of single or multiple brain metastasis without whole-brain radiotherapy. Booklet of ASCO meeting: 93–99

    Google Scholar 

  140. Kojima H, Tanigawa N, Kariya S, Komemushi A, Shomura Y, Sawada S (2006) Clinical assessment of percutaneous radiofrequency ablation for painful metastatic bone tumors. Cardiovasc Intervent Radiol 6: 1022–1026

    Article  Google Scholar 

  141. Kondziolka D, Patel A, Lunsford LD et al. (1999) Stereotactic radiosurgery plus whole-brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45: 427–434

    PubMed  CAS  Google Scholar 

  142. Kreisman H, Wolkove N, Finkelstein HS, Cohen C, Margolese R, Frank H (1983) Breast cancer and thoracic metastases: review of 119 patients. Thorax 38: 175–179

    Article  PubMed  CAS  Google Scholar 

  143. Kristensen B et al. (1999) Oral clodronate in breat cancer patients with bone metastases a randomized study. J Intern Med 246: 67–74

    Article  PubMed  CAS  Google Scholar 

  144. Kvitting JP, Sandstrom P, Thorelius L, Kullman E, Borch K, Svanvik J (2006) Radiofrequency ablation of a liver metastasis complicated by extensive liver necrosis and sepsis caused by gas gangrene. Surgery 139: 123–125

    Article  PubMed  Google Scholar 

  145. Lagana D, Carrafiello G, Mangini M et al. (2006) Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc 20: 1262–1267

    Article  PubMed  CAS  Google Scholar 

  146. Landheer ML, Steffens MG, Klinkenbijl JH et al. (2005) Value of fluorodeoxyglucose positron emission tomography in women with breast cancer. Br J Surg 92: 1363–1367

    Article  PubMed  CAS  Google Scholar 

  147. Lanza LA, Natarajan G, Roth JA et al. (1992) Long term survival after resectiobn of pulmonary metastases from carcinoma of the breast. Ann Thoac Surg 54: 244–248

    Article  CAS  Google Scholar 

  148. Lauenstein TC, Goehde SC, Herborn CU et al. (2004) Whole-Body MR Imaging: Evaluation of Patients for Metastases. Radiology 233: 139–148

    Article  PubMed  Google Scholar 

  149. Lauenstein TC, Goehde SC, Herborn CU et al. (2002) Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. Am J Roentgenol 179: 445–449

    Google Scholar 

  150. Lawes D, Chopada A, Gillams A, Lees W, Taylor I (2006) Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl 88: 639–642

    Article  PubMed  CAS  Google Scholar 

  151. Le Scodan R, Massard C, Mouret-Fourme E et al. (2007) Brain metastases from breast carcinoma: validation of the Radiation Therapy Oncology Group Recursive Partitionning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys 69: 839–845

    Article  PubMed  Google Scholar 

  152. Lee WS, Yun SH, Chun HK et al. (2008) Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 42: 945–949

    Article  PubMed  Google Scholar 

  153. Lemarie E, Milleron B (1999) Pleuropulmonary metastases of female cancers. Rev Pneumol Clin 55: 271–279

    PubMed  CAS  Google Scholar 

  154. Lencioni R, Crocetti L, Cioni R et al. (2008) Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9: 621–628

    Article  PubMed  Google Scholar 

  155. Lermite E, Lebigot J, Oberti F et al. (2006) Radiofrequency thermal ablation of liver carcinoma. Prospective study of 82 lesions. Gastroenterol Clin Biol 30: 130–135

    Article  PubMed  Google Scholar 

  156. Leyland-Jones B, Gelmon K, Ayoub JP et al. (2003) Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel. J Clin Oncol 21: 3965–3971

    Article  PubMed  CAS  Google Scholar 

  157. Li J, Bentzen SM, Renschler M et al. (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Bio Phys 71: 64–70

    Article  Google Scholar 

  158. Li XP, Meng ZQ, Guo WJ, Li J (2005) Treatment for liver metastases from breast cancer: results and prognostic factors.World J Gastroenterol 11: 3782–3787

    Google Scholar 

  159. Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22: 3608–3617

    Article  PubMed  Google Scholar 

  160. Lin NU, Carey LA, Liu MC et al. (2008) Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer 1. J Clin Oncol 26: 1993–1999

    Article  PubMed  CAS  Google Scholar 

  161. Lipton A et al. (2000) Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer 88: 1082–1090

    Article  PubMed  CAS  Google Scholar 

  162. Liu MT, Hsieh CY, Wang AY et al. (2006) Prognostic factors affecting the outcome of brain metastases from breast cancer. Supportive Care Cancer 14: 936–942

    Article  Google Scholar 

  163. Livartowski A, Chapelier A, Beuzeboc P (1998) Surgery of lung metastases of breast cancer: analysis of 40 cases. Bull Cancer 85: 799–802

    PubMed  CAS  Google Scholar 

  164. Lo WK, vansonnenberg E, Shankar S et al. (2006) Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol 17: 175–179

    Article  PubMed  Google Scholar 

  165. Loblaw DA, Laperriere NJ (1998) Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 16: 1613–1624

    PubMed  CAS  Google Scholar 

  166. Lower EE, Drosick DR, Blau R, Brennan L, Danneman W, Hawley DK (2003) Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival 1. Clin Breast Cancer 4: 114–119

    Article  PubMed  CAS  Google Scholar 

  167. Machi J, Bueno RS, Wong LL (2005) Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 29: 1364–1373

    Article  PubMed  Google Scholar 

  168. Mardiak J et al. (2000) Adjuvant clodronate therapy in patients with locally advanced breast cancer-long term results of a double blind randomized trial. Neoplasma 47: 177–180

    PubMed  CAS  Google Scholar 

  169. Martoni A et al. (1991) Controlled clinical strudy on the use of dichloromethylen diphosphonate in patients with breast carcinoma metastasizing to the skeleton. Oncology 48: 97–101

    Article  PubMed  CAS  Google Scholar 

  170. Marty M, Cognetti F, Maraninchi D et al. (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 Study Group. J Clin Oncol 23: 4265–4274

    Article  PubMed  CAS  Google Scholar 

  171. Masood S, Bui MM (2000) Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study. Ann Clin Lab Sci 30: 259–265

    PubMed  CAS  Google Scholar 

  172. Mayo-Smith WW, Dupuy DE (2004) Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 231: 225–230

    Article  PubMed  Google Scholar 

  173. McDonald ML, Deschamps C, Ilstrup DM et al. (1994) Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 58: 1599–1602

    Article  PubMed  CAS  Google Scholar 

  174. McCarty TM, Kuhn JA (1998) Cryotherapy for liver tumors. Oncology (Williston Park) 12: 979–987; discussion 990–3

    CAS  Google Scholar 

  175. Mehta MP, Tsao MN, Whelan TJ et al. (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiation Oncol Biol Phys 63: 37–46

    Article  Google Scholar 

  176. Meng S, Tripathy D, Shete S et al. (2004) HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA 101: 9393–9398

    Article  PubMed  CAS  Google Scholar 

  177. Metro G, Sperduti I, Russillo M, Milella M, Cognetti F, Fabi A (2007) Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer 4. Oncologist 12: 1467–1469

    Article  PubMed  Google Scholar 

  178. Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA (2002) Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 168: 2406–2409; discussion 2409–10

    Article  PubMed  Google Scholar 

  179. Miles D, Chan A, Romieu CG et al. (2008) Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (MBC): AVADO. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 26:43S, ASCO meeting 2008, Chicago USA

    Google Scholar 

  180. Miller K, Wang M, Gralow J et al. (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer 1. N Engl J Med 357: 2666–2676

    Article  PubMed  CAS  Google Scholar 

  181. Miller KD, Chap LI, Holmes F et al. (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer 158. J Clin Oncol 23: 792–799

    Article  PubMed  CAS  Google Scholar 

  182. Miller KD, Weathers T, Haney LG et al. (2003) Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol 14: 1072–1077

    Article  PubMed  CAS  Google Scholar 

  183. Moskovic E, Parsons C, Baum M (1992) Chest radiography in the management of breast cancer. Br J Radiol 65: 30–32

    Article  PubMed  CAS  Google Scholar 

  184. Murabito M, Salat A, Mueller MR (2000) Complete resection of isolated lung metastasis from breast cancer results in a strong increase in survival. Minerva Chir 55: 121–127

    PubMed  CAS  Google Scholar 

  185. Namer M, Antoine EC, Le Deley MC et al. (2005) Effect of trastuzumab treatment as first-line on metastatic breast cancer: final results of the French HERMINE cohort after 2-year follow-up (n = 221). SABCS 2005: abstract 2036

    Google Scholar 

  186. Namer M, Catimel G, Mauriac L (1994) 6 % Miltefosine solution (MIL) locally used as single palliative therapy in cutaneous metastases from breast cancer. Ann Oncol 5 (suppl 8)

    Google Scholar 

  187. Niehans GA, Singleton TP, Dykoski D, Kiang DT (1993) Stability of HER-2/neu expression over time and at multiple metastatic sites. J Natl Cancer Inst 85: 1230–1235

    Article  PubMed  CAS  Google Scholar 

  188. Ogura M, Mitsumori M, Okumura S et al. (2003) Radiation therapy for brain metastases from breast cancer. Breast Cancer 10: 349–355

    Article  PubMed  Google Scholar 

  189. Ohno Y, Koyama H, Onishi Y et al. (2008) Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248: 643–654

    Article  PubMed  Google Scholar 

  190. O’Shaughnessy J, Blackwell KL, Burstein H et al. (2008) A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy. ASCO Annual Meeting 2008: Abstract 1015

    Google Scholar 

  191. Pacella CM, Valle D, Bizzarri G et al. (2006) Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II study. Acta Oncol 45: 77–83

    Article  PubMed  Google Scholar 

  192. Palmieri D, Bronder JL, Herring JM et al. (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain 5. Cancer Research 67: 4190–4198

    Article  PubMed  CAS  Google Scholar 

  193. Patchell RA, Regine WF, Loeffler JS et al. (2006) Radiosurgery plus whole-brain radiation therapy for brain metastases. JAMA 296: 2089–2091

    Article  PubMed  CAS  Google Scholar 

  194. Patchell RA, Tibbs PA, Regine WF et al. (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomized trial. Lancet 366: 643–648

    Article  PubMed  Google Scholar 

  195. Patchell RA, Tibbs PA, Regine WF et al. (1998) Post operative radiotherapy in the treatment of single metastases in the brain: a randomized trial. JAMA 280: 1485–1489

    Article  PubMed  CAS  Google Scholar 

  196. Patchell RA, Tibbs PA, Walsh JW et al. (1990) A randomized trial of surgery in the management of single brain metastases to the brain. N Engl J Med 322: 494–500

    Article  PubMed  CAS  Google Scholar 

  197. Paterson AHG et al. (1993) Double-blind controlled trial of oral clodronate in patient bone metastases from breast cancer. J Clin Oncol 11: 59–65

    PubMed  CAS  Google Scholar 

  198. Pearson AS, Izzo F, Fleming RY et al. (1999) Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178: 592–599

    Article  PubMed  CAS  Google Scholar 

  199. Pectasides D, Gaglia A, Arapantoni-Dadioti P et al. (2006) HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy. AntiCancer Res 26(1B): 647–653

    PubMed  CAS  Google Scholar 

  200. Perez EA, Suman VJ, Rowland KM et al. (2005) Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer 6: 425–432

    Article  PubMed  CAS  Google Scholar 

  201. Pertschuk LP, Axiotis CA, Feldman JG et al. (1999) Marked intratumoral heterogeneity of the proto-oncogene Her-2/neu determined by three different detection systems. Breast J 5: 369–374

    Article  PubMed  Google Scholar 

  202. Pestalozzi BC, Zahrieh D, Price KN et al. (2006) Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trial of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17: 935–944

    Article  PubMed  CAS  Google Scholar 

  203. Planchard D, Soria JC, Michiels S et al. (2004) Uncertain Benefit from surgery in patients with lung metastases from breast cancer. Cancer 100: 28–35

    Article  PubMed  Google Scholar 

  204. Pocard M, Pouillart P, Asselain B et al. (2001) Resections hépatiques pour métastases de cancer du sein: résultats et facteurs pronostiques (65 cas). Ann Chir 126: 413–420

    Article  PubMed  CAS  Google Scholar 

  205. Pocard M, Pouillart P, Asselain B, Salmon R (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 26: 155–159

    Article  PubMed  CAS  Google Scholar 

  206. Pohlen U, Rieger H, Albrecht T, Loddenkemper C, Buhr HJ, Schneider P (2007) Chemoembolization with carboplatin of the lung. Feasibility and toxicity in a pig model. AntiCancer Res 27: 1503–1508

    PubMed  CAS  Google Scholar 

  207. Pohlen U, Rieger H, Meyer BT et al. (2007) Chemoembolization of lung metastases—pharmacokinetic behaviour of carboplatin in a rat model. AntiCancer Res 27: 809–815

    PubMed  CAS  Google Scholar 

  208. Powles T et al. (2002) Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 15: 3219–3224

    Article  CAS  Google Scholar 

  209. Press MF, Finn RS, Di Leo A et al. (2008) Correlation of HER2 gene amplification, HER2 and EGFR expression (protein and mRNA) with lapatinib efficacy in women with metastatic breast cancer. J Clin Oncol 26(Suppl): abstract 1007

    Google Scholar 

  210. Raab R, Nussbaum KT, Behrend M et al. (1998) Liver metastases of breast cancer: results of liver resection. AntiCancer Res 18: 2231–2233

    PubMed  CAS  Google Scholar 

  211. Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O (2006) The role of FDG-PET/CT in suspected recurrence of breast cancer. Cancer 107: 2545–2551

    Article  PubMed  Google Scholar 

  212. Rades D, Veninga T, Stalpers LJ et al. (2007) Outcome after radiotherapy alone for metastatic spinal in patients with oligometastases. J Clin Oncol 25: 50–56

    Article  PubMed  Google Scholar 

  213. Rades D, Veninga T, Stalpers LJ et al. (2006) Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 64: 182–188

    Article  PubMed  Google Scholar 

  214. Radin EL, Rubin CT, Thrasher EL et al. (1982) Changes in the bone cement interface after total hip replacement. J Bone Joint Surg 64: 1188–1200

    PubMed  CAS  Google Scholar 

  215. Radin NS, Rittenberg D and Shemin D (1950) The role of acetic acid in the biosynthesis of heme. J Biol Chem 2: 755–767

    Google Scholar 

  216. Raizer J (2006) Radiosurgery and whole-brain radiation therapy for brain metastases. JAMA 295: 2535–2536

    Article  PubMed  CAS  Google Scholar 

  217. Rao R, Feng L, Kuerer HM et al. (2008) Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15: 1696–1702

    Article  PubMed  Google Scholar 

  218. Rapiti E, Verkooijen HM, Vlastos G et al. (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24: 2743–2749

    Article  PubMed  Google Scholar 

  219. Rath GK, Julka PK, Thulkar S, Sharma DN, Bahl A, Bhatnagar S (2008) Radiofrequency ablation of hepatic metastasis: results of treatment in forty patients. J Cancer Res Ther 4: 14–17

    PubMed  CAS  Google Scholar 

  220. Rena O, Papalia E, Ruffini E, Filosso PL, Oliaro A, Maggi G, Casadio C (2007) The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 33: 546–50

    Article  PubMed  CAS  Google Scholar 

  221. Rendon RA, Kachura JR, Sweet JM et al. (2002) The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 167: 1587–1592

    Article  PubMed  Google Scholar 

  222. Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC (2009) Radiofrequency ablation vs resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13: 486–491

    Article  PubMed  Google Scholar 

  223. Robert N, Leyland-Jones B, Asmar L et al. (2006) Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer. J Clin Oncol 24: 2786–2792

    Article  PubMed  CAS  Google Scholar 

  224. Roche A, Girish BV, de Baere T et al. (2004) Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. Hepatogastroenterology 51: 1751–1756

    PubMed  CAS  Google Scholar 

  225. Rohren EM, Provenzale JM, Barboriak DP, Coleman R (2003) Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 226: 181–187

    Article  PubMed  Google Scholar 

  226. Rose SC (2008) Radiofrequency ablation of pulmonary malignancies. Semin Respir Crit Care Med 29: 361–383

    Article  PubMed  Google Scholar 

  227. Rosen LS et al. (2003) Zoledromic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with least one osteolytic lesion. Cancer 100: 36–43

    Article  CAS  Google Scholar 

  228. Rougier P, Lasser P, Elias D (1992) Chimiothérapie des métastases hépatiques d’origine colorectale (systémique et loco-régionale en traitement palliatif ou adjuvant). In: Nordlinger B, Jaeck D, eds. Monographies de l’association française de chirurgie: traitement des métastases hépatiques des cancers colorectaux. Paris: Springer-Verlag

    Google Scholar 

  229. Saarto T et al. (2001) Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node positive breast cancer patients: 5-years of results of randomized controlled trial. J Clin Oncol 1: 10–17

    Google Scholar 

  230. Sakamoto Y, Yamamoto J, Yoshimoto M et al. (2005) Hepatic resection for breast cancer: prognosic analysis of 34 patients. World J Surg 29: 524–527

    Article  PubMed  Google Scholar 

  231. Santinelli A, Pisa E, Stramazzotti D, Fabris G (2008) HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy. Int J Cancer 122: 999–1004

    Article  PubMed  CAS  Google Scholar 

  232. Scheid V, Buzdar AU, Smith TL, Hortobagyi GN (1986) Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 58: 2589–2593

    Article  PubMed  CAS  Google Scholar 

  233. Schmidt GP, Baur-Melnyk A, Herzog P et al. (2005) High-resolution wholebody magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40: 743–753

    Article  PubMed  Google Scholar 

  234. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55: 26–31; discussion 32

    Article  PubMed  CAS  Google Scholar 

  235. Schneider P, Kampfer S, Loddenkemper C, Foitzik T, Buhr HJ (2002) Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res 8: 2463–2468

    PubMed  CAS  Google Scholar 

  236. Seifert JK, Morris DL (1998) Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 228: 201–208

    Article  PubMed  CAS  Google Scholar 

  237. Seifert JK, Weigel TF, Gonner U, Bottger TC, Junginger T (1999) Liver resection for breast cancer metastases. Hepatogastroenterology 46: 2935–2940

    PubMed  CAS  Google Scholar 

  238. Selzner M, Morse MA, Vredenburgh JJ et al. (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127: 383–389

    Article  PubMed  CAS  Google Scholar 

  239. Sharma KV, Gould JE, Harbour JW et al. (2008) Hepatic arterial chemoembolization for management of metastatic melanoma. Am J Roentgenol 190: 99–104

    Article  Google Scholar 

  240. Sheen AJ, Poston GJ, Sherlock DJ (2002) Cryotherapeutic ablation of liver tumours. Br J Surg 89: 1396–1401

    Article  PubMed  CAS  Google Scholar 

  241. Shehata MK, Young B, Reid B et al. (2004) Stereotactic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiation Oncol Biol Phys 59: 87–99

    Article  Google Scholar 

  242. Sherry MM, Greco FA, Johnson DH, Hainsworth JD (1986) Metastatic breast cancer confined to the skeletal system. An indolent disease. Am J Med 81: 381–386

    Article  PubMed  CAS  Google Scholar 

  243. Shetty SK, Rosen MP, Raptopoulos V, Goldberg SN (2001) Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol 12: 823–833

    Article  PubMed  CAS  Google Scholar 

  244. Shiina S, Niwa Y, Hata Y (1990) Percutaneous ethanol injection therapy for liver neoplasms: value of using multiple needles. Am J Roentgenol 155: 420–421

    CAS  Google Scholar 

  245. Shimizu C, Fukutomi T, Tsuda H et al. (2000) c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues. J Surg Oncol 73: 17–20

    Article  PubMed  CAS  Google Scholar 

  246. Simon CJ, Dupuy DE, DiPetrillo TA et al. (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243: 268–275

    Article  PubMed  Google Scholar 

  247. Simpson R, Kennedy C, Carmalt H et al. (1997) Pulmonary resection for metastatic breast cancer. Aust N Z J Surg 67: 717–719

    Article  PubMed  CAS  Google Scholar 

  248. Singletary SE, Walsh G, Vauthey JN et al. (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. The Oncologist 8: 241–251

    Article  PubMed  Google Scholar 

  249. Slamon DJ, Eiermann W, Robert N et al. (2005) Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab (TCH) in HER2 positive early breast cancer patients: BCIRG 006 Study. Breast Cancer ResTreat. 94:S5, San Antonio Breast Cancer Symposium 2005

    Google Scholar 

  250. Slamon DJ, Eiermann W, Robert N et al. (2006) BCIRG 006: 2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (ACT) with doxorubicin and cyclophosphamide followed by docétaxel and trastuzumab (ACTH) with docetaxel, carboplatin and trastuzumab (TCH) in Her2neu positive early breast cancer patients. Breast Cancer Res Treat 100, SABCS 2006, San Antonio, USA

    Google Scholar 

  251. Slamon DJ, Leyland-Jones B, Shak S et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783–792

    Article  PubMed  CAS  Google Scholar 

  252. Sneed PK, Suh JH, Goetsch SJ et al. (2002) A multi-institutional review of radiosurgery alone vs radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiation Oncol Biol Phys 53: 519–526

    Article  Google Scholar 

  253. Solbiati L, Livraghi T, Goldberg SN et al. (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221: 159–166

    Article  PubMed  CAS  Google Scholar 

  254. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59: 271–278

    Article  PubMed  CAS  Google Scholar 

  255. Soltys SG, Adler JR, Lipani JD et al. (2008) Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 70: 187–193

    Article  PubMed  Google Scholar 

  256. Sparano JA, Goldstein L, Childs BH et al.; North American Breast Cancer Intergroup (2008) Relationship between TOP2A expression and recurrence after adjuvant doxorubicin-containing chemotherapy for operable breast cancer in Intergroup trial E2197. ASCO 2008: abstract 90

    Google Scholar 

  257. Stafinski T, Jhangri GS, Yan E et al. (2006) Effectiveness of stereotactic radiosurgery alone or in combinatio with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 32: 203–213

    Article  PubMed  Google Scholar 

  258. Steele G, Jr, Ravikumar TS, Benotti PN (1990) New surgical treatments for recurrent colorectal cancer. Cancer 65: 723–730

    Article  PubMed  Google Scholar 

  259. Steger AC, Lees WR, Walmsley K, Bown SG (1989) Interstitial laser hyperthermia: a new approach to local destruction of tumours. Br Med J 299: 362–365

    Article  CAS  Google Scholar 

  260. Stehlin JS, de Ipolyi PD, Greeff PJ, McGaff CJ, Jr., Davis BR, McNary L (1988) Treatment of cancer of the liver. Twenty years’ experience with infusion and resection in 414 patients. Ann Surg 208: 23–35

    Article  PubMed  Google Scholar 

  261. Steinke K, King J, Glenn D, Morris DL (2003) Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed? Interact Cardiovasc Thorac Surg 2: 462–465

    Article  PubMed  Google Scholar 

  262. Sze G, Shin J, Krol G, Johnson C, Liu D, Deck MD (1988) Intraparenchymal brain metastases: MR imaging versus contrast-enhanced CT. Radiology 168: 187–194

    PubMed  CAS  Google Scholar 

  263. Tanaka F, Li M, Hanaoka N et al. (2005) Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg 79: 1711–1715

    Article  PubMed  Google Scholar 

  264. Tapia C, Savic S, Wagner U et al. (2007) HER2 gene status in primary breast cancers and matched distant metastases. Breast Cancer Res 9: R31

    Article  PubMed  CAS  Google Scholar 

  265. Tarcoveanu E, Zugun F, Mehier H et al. (2005) Palliative therapy for malignant hepatic tumors with hyperthermia. Rev Med Chir Soc Med Nat 109: 516–527

    CAS  Google Scholar 

  266. Taucher S, Rudas M, Mader RM et al. (2003) Influence of neoadjuvant therapy with epirubicin and docétaxel on the expression of HER2/neu in patients with breast cancer. Breast Cancer Res Treat 82: 207–213

    Article  PubMed  CAS  Google Scholar 

  267. Theriault RL et al. (1999) Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial. J Clin Oncol 17: 846–854

    PubMed  CAS  Google Scholar 

  268. Townsend PW, Rosenthal HG, Smalley SR et al. (1994) Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopaedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 12: 2345–2350

    PubMed  CAS  Google Scholar 

  269. Tripathy D et al. (2004) Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from randomized, double-blind, placebo-controlled trial. Ann Oncol 15: 743–750

    Article  PubMed  CAS  Google Scholar 

  270. Tubiana-Hulin et al. (2001) Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone. Bull Cancer 88: 701–707

    PubMed  CAS  Google Scholar 

  271. Ural AU, Avcu F, Baran Y (2008) Bisphosphonates treatment and radiotherapy in metastatic breast cancer. Med Oncol 25: 350–355

    Article  PubMed  CAS  Google Scholar 

  272. Van der Hoeven JJ, Krak NC, Hoekstra OS et al. (2004) 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 22: 1253–1259

    Article  PubMed  CAS  Google Scholar 

  273. Van Holten-Verzantvoort ATM et al. (1996) Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breats cancer patients? Eur J Cancer 3(32A): 450–454

    Article  Google Scholar 

  274. VanSonnenberg E, Shankar S, Morrison PR et al. (2005) Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience—technical and multidisciplinary considerations in 30 patients. Am J Roentgenol 184: 381–390

    Google Scholar 

  275. Viadana E, Bross ID, Pickren JW (1973) An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27: 336–340

    Article  PubMed  CAS  Google Scholar 

  276. Vincent-Salomon A, Jouve M, Genin P et al. (2002) HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process. Cancer 94: 2169–2173

    Article  PubMed  CAS  Google Scholar 

  277. Vincent-Salomon A, Pierga JY, Couturier J et al. (2007) HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? Br J Cancer 96: 654–659

    Article  PubMed  CAS  Google Scholar 

  278. Vlastos G, Smith D, Singletary SE et al. (2004) Long term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11: 869–874

    Article  PubMed  Google Scholar 

  279. Vogel CL, Cobleigh MA, Tripathy D et al. (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20: 719–726

    Article  PubMed  CAS  Google Scholar 

  280. Von Holten-Verzantvoot ATM et al. (1993) Palliative pamidronate traetement in patients with bone metastases from breast cancer. J Clin Oncol 11: 491–498

    Google Scholar 

  281. Von Minckwitz G, du Bois A, Schmidt M et al. (2009) Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. J Clin Oncol 27: 1999–2006

    Article  CAS  Google Scholar 

  282. Walker R, Kessar P, Blanchard R et al. (2000) Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11: 343–350

    Article  PubMed  CAS  Google Scholar 

  283. Ward E, Munk PL, Rashid F, Torreggiani WC (2008) Musculoskeletal interventional radiology: radiofrequency ablation. Radiol Clin North Am 46: 599–610, vi–vii

    Article  PubMed  Google Scholar 

  284. Watanabe M, Nakazaki H, Takada M et al. (2004) The results of liver cryosurgery for synchronized liver metastasis from colorectal cancer. Gan To Kagaku Ryoho 31: 1882–1884

    PubMed  Google Scholar 

  285. Weaver ML, Ashton JG, Zemel R (1998) Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 14: 163–170

    Article  PubMed  CAS  Google Scholar 

  286. Wefel JS (2006) Neurocognitive sequelae of whole brain radiotherapy in patients with brain metastases. Booklet of ASCO meeting 2006: 100–104

    Google Scholar 

  287. Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E (1996) Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 241: 7

    Google Scholar 

  288. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T (2003) Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97: 554–560

    Article  PubMed  Google Scholar 

  289. Wronski M, Arbit E, McCormick B (1997) Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80: 1746–1754

    Article  PubMed  CAS  Google Scholar 

  290. Wu JM, Fackler MJ, Halushka MK et al. (2008) Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res 14: 1938–1946

    Article  PubMed  CAS  Google Scholar 

  291. Xiao YY, Tian JL, Li JK, Yang L, Zhang JS (2008) CT-guided percutaneous chemical ablation of adrenal neoplasms. Am J Roentgenol 190: 105–110

    Article  Google Scholar 

  292. Yamakado K, Hase S, Matsuoka T et al. (2007) Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18: 393–398

    Article  PubMed  Google Scholar 

  293. Yamakado K, Nakatsuka A, Takaki H et al. (2005) Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol 16: 1747–1751

    PubMed  Google Scholar 

  294. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K (1999) Detection of brain metastasis in potentially operable non-small cell lung cancer: A comparison of CT and MRI. Chest 115: 714–719

    Article  PubMed  CAS  Google Scholar 

  295. Yoshimoto M, Tada T, Saito M et al. (2000) Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 59: 177–184

    Article  PubMed  CAS  Google Scholar 

  296. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G (1987) Clinical course of breast cancer patients with liver metastases. J Clin Oncol 5: 773–782

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de médecine, Centre Léon Bérard, 28, rue Laennec, 69373, Lyon Cedex 08

    J.-P. Guastalla

  2. Centre Oscar Lambret, 3, rue Frédéric Combemale, 59020, Lille Cedex

    S. Giard

  3. Service d’oncologie médicale, Centre Georges-François Leclerc, 1, rue du Pr Marion, 21079, Dijon Cedex

    B. Coudert

  4. Service de neuroradiolgoie diagnostique et interventionnelle, Groupe hospitalier Pitié-Salpêtrière, 47, boulevard de l’Hôpital, 75013, Paris

    J. Chiras

Authors
  1. J.-P. Guastalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Campone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Zelek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. M. Guinebretière
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Giard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Ganem
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Coudert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Chiras
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Guastalla, JP. et al. (2010). Cancer du sein métastatique. In: Cancer du sein en situation métastatique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0076-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0076-9_37

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0075-2

  • Online ISBN: 978-2-8178-0076-9

Publish with us

Policies and ethics

Search

Navigation